Sign up for the QMED & MD+DI Daily newsletter.
October 7, 2016
1 Min Read
Data can help inform patient treatment and ultimately improve care--or at least that's the dream. In reality, many connected health solutions drown users in a deluge of data that their healthcare providers may or may not be able to trust. Abbott's FreeStyle Libre Pro System for continuous glucose monitoring, which recently won FDA approval, gets it right with a more strategic approach. A healthcare professional outfits patients with a small sensor, worn on the back of the arm, that measures glucose levels every 15 minutes for up to 14 days. After those two weeks, the patent returns to the doctor's office, where their physician scans the sensor to download the data for review and discussion.
[Image courtesy of ABBOTT LABORATORIES]
You May Also Like
Sustainable Manufacturing Expo Hits North AmericaFeb 22, 2024|4 Min Read
Medtronic Doubles Down on Sustainability EffortsFeb 22, 2024|1 Min Read
Top Medical Device M&AFeb 21, 2024|1 Min Read
FDA Urges Independent Verification of Third-Party Testing DataFeb 21, 2024|2 Min Read